Computed tomography-based radiomics nomogram for the pre-operative prediction of BRAF mutation and clinical outcomes in patients with colorectal cancer: a double-center study.

OBJECTIVE To develop and validate a radiomics nomogram based on CT for the pre-operative prediction of BRAF mutation and clinical outcomes in patients with colorectal cancer (CRC). METHODS A total of 451 CRC patients (training cohort = 190; internal validation cohort = 125; external validation cohort = 136) from 2 centers were retrospectively included. Least absolute shrinkage and selection operator regression was used to select radiomics features and the radiomics score (Radscore) was calculated. Nomogram was constructed by combining Radscore and significant clinical predictors. Receiver operating characteristic curve analysis, calibration curve and decision curve analysis were used to evaluate the predictive performance of the nomogram. Kaplan‒Meier survival curves based on the radiomics nomogram were used to assess overall survival (OS) of the entire cohort. RESULTS The Radscore consisted of nine radiomics features which were the most relevant to BRAF mutation. The radiomics nomogram integrating Radscore and clinical independent predictors (age, tumor location and cN stage) showed good calibration and discrimination with AUCs of 0.86 (95% CI: 0.80-0.91), 0.82 (95% CI: 0.74-0.90) and 0.82 (95% CI: 0.75-0.90) in the training cohort, internal validation and external validation cohorts, respectively. Furthermore,the performance of nomogram was significantly better than that of the clinical model (p < 0.05). The radiomics nomogram-predicted BRAF mutation high-risk group had a worse OS than the low-risk group (p < 0.0001). CONCLUSION The radiomics nomogram showed good performance in predicting BRAF mutation and OS of CRC patients, which could provide valuable information for individualized treatment. ADVANCES IN KNOWLEDGE The radiomics nomogram could effectively predict BRAF mutation and OS in patients with CRC. High-risk BRAF mutation group identified by the radiomics nomogram was independently associated with poor OS.

[1]  J. Chen,et al.  CT radiomics nomogram for prediction of the Ki-67 index in head and neck squamous cell carcinoma , 2022, European Radiology.

[2]  Xuehua Xi,et al.  Nomogram based on radiomics analysis of ultrasound images can improve preoperative BRAF mutation diagnosis for papillary thyroid microcarcinoma , 2022, Frontiers in Endocrinology.

[3]  Qiaoling Chen,et al.  Preoperative prediction of KRAS mutation status in colorectal cancer using a CT-based radiomics nomogram. , 2022, The British journal of radiology.

[4]  Qiaoling Chen,et al.  A CT-Based Radiomics Nomogram in Predicting the Postoperative Prognosis of Colorectal Cancer: A Two-center Study. , 2022, Academic radiology.

[5]  Guangjie Yang,et al.  The value of 18F-FDG PET/CT-based radiomics in predicting perineural invasion and outcome in non-metastatic colorectal cancer , 2022, Abdominal Radiology.

[6]  Ting Zhao,et al.  The application of radiomics in predicting gene mutations in cancer , 2022, European Radiology.

[7]  Chencui Huang,et al.  Computed tomography-based radiomics for predicting lymphovascular invasion in rectal cancer. , 2021, European journal of radiology.

[8]  Qingling Li,et al.  Pre-treatment CT-based radiomics nomogram for predicting microsatellite instability status in colorectal cancer , 2021, European Radiology.

[9]  Y. Nam,et al.  Development and Validation of a Radiomics Model for Differentiating Bone Islands and Osteoblastic Bone Metastases at Abdominal CT. , 2021, Radiology.

[10]  J. Meyerhardt,et al.  Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[11]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[12]  OUP accepted manuscript , 2021, Neuro-Oncology.

[13]  A. Minelli,et al.  The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference , 2020, International Journal of Colorectal Disease.

[14]  M. Harisinghani,et al.  Imaging predictors of BRAF mutation in colorectal cancer , 2020, Abdominal Radiology.

[15]  Verónica Bolón-Canedo,et al.  A review of feature selection methods in medical applications , 2019, Comput. Biol. Medicine.

[16]  P. Laurent-Puig,et al.  Molecular targeted therapy of BRAF-mutant colorectal cancer , 2019, Therapeutic advances in medical oncology.

[17]  Yajian Wang,et al.  Mutation in BRAF and SMAD4 associated with resistance to neoadjuvant chemoradiation therapy in locally advanced rectal cancer , 2019, Virchows Archiv.

[18]  Hidetaka Arimura,et al.  Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition‐based radiomic features , 2018, Medical physics.

[19]  P. Lønning,et al.  Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer , 2018, JAMA surgery.

[20]  Di Dong,et al.  Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer? , 2018, European Radiology.

[21]  J. Tabernero,et al.  BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  T. Bekaii-Saab,et al.  Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches. , 2017, Cancer treatment reviews.

[23]  Robyn L. Temple-Smolkin,et al.  Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. , 2017, The Journal of molecular diagnostics : JMD.

[24]  Geoffrey G. Zhang,et al.  Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels , 2017, Medical physics.

[25]  J. Cicenas,et al.  KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma , 2017, Medical Oncology.

[26]  C. Atreya,et al.  Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[27]  D. Sargent,et al.  Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147. , 2014, Journal of the National Cancer Institute.

[28]  Benjamin Haibe-Kains,et al.  mRMRe: an R package for parallelized mRMR ensemble feature selection , 2013, Bioinform..

[29]  P. Gibbs,et al.  Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer , 2011, Cancer.